NetTargets and Cellkey sign MoU to collaborate on biomarker discovery
NetTargets Inc.
09 Jun 2021
NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.